Meta-Analysis Reveals no Significant Association between ERCC6 Polymorphisms and Bladder Cancer Risk. Issue 1 (January 2017)
- Record Type:
- Journal Article
- Title:
- Meta-Analysis Reveals no Significant Association between ERCC6 Polymorphisms and Bladder Cancer Risk. Issue 1 (January 2017)
- Main Title:
- Meta-Analysis Reveals no Significant Association between ERCC6 Polymorphisms and Bladder Cancer Risk
- Authors:
- Hong, Zhengdong
Wu, Jinxian
Li, Qiang
Zhang, Shouhua
Shi, Zimin - Abstract:
- Background: Numerous studies have been conducted to evaluate the association between excision repair cross-complementing group 6 (ERCC6) gene polymorphisms and bladder cancer risk, but their findings have been inconsistent. Here we performed a meta-analysis to attempt to clarify this association. Methods: Studies were retrieved from the PubMed and China National Knowledge Infrastructure databases up to October 1, 2015, with strict selection and exclusion criteria. A total of 5, 032 samples, comprising samples from 2, 475 bladder cancer patients and 2, 557 controls from 5 studies, were included in the meta-analysis. The odds ratio (OR) with 95% confidence interval (CI) was used to evaluate the strength of the associations. Results: Regarding the Met1097Val polymorphism, no significant association with bladder cancer risk was found in any of the genetic models evaluated (Val vs. Met: OR = 1.10, 95% CI, 0.97-1.25; Val/Val vs. Met/Met: OR = 1.23, 95% CI, 0.86-1.75; Val/Val + Val/Met vs. Met/Met: OR = 1.12, 95% CI, 0.96-1.30; Val/Val vs. Met/Met + Val/Met: OR = 0.81, 95% CI, 0.57-1.14). Similarly, as regards the Arg1230Pro polymorphism, we also found no positive results. Conclusions: According to the results of our meta-analysis, there is no evidence of a link between the ERCC6 gene polymorphisms and bladder cancer risk. Well-designed further studies, with larger sample sizes and adjustment for confounders such as smoking status, are needed to confirm these conclusions.
- Is Part Of:
- International journal of biological markers. Volume 32:Issue 1(2017)
- Journal:
- International journal of biological markers
- Issue:
- Volume 32:Issue 1(2017)
- Issue Display:
- Volume 32, Issue 1 (2017)
- Year:
- 2017
- Volume:
- 32
- Issue:
- 1
- Issue Sort Value:
- 2017-0032-0001-0000
- Page Start:
- 113
- Page End:
- 117
- Publication Date:
- 2017-01
- Subjects:
- Bladder cancer -- ERCC6 -- Meta-analysis -- Polymorphism
Cell receptors -- Periodicals
Histochemistry -- Periodicals
Tumor markers -- Periodicals
Tumor antigens -- Periodicals
616.99407582 - Journal URLs:
- http://journals.sagepub.com/home/jbm ↗
http://www.uk.sagepub.com/home.nav ↗ - DOI:
- 10.5301/jbm.5000236 ↗
- Languages:
- English
- ISSNs:
- 0393-6155
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 8353.xml